U.S., June 27 -- ClinicalTrials.gov registry received information related to the study (NCT07038200) titled 'A Study to Evaluate Del-brax (Also Referred to as AOC 1020) in Participants With FSHD' on June 13.
Brief Summary: A Randomized, Double-blind, Placebo-controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Intravenous AOC 1020 for the Treatment of Facioscapulohumeral Muscular Dystrophy (FSHD)
Study Start Date: June 10
Study Type: INTERVENTIONAL
Condition:
Facioscapulohumeral Muscular Dystrophy
FSHD
FSHD - Facioscapulohumeral Muscular Dystrophy
FSHD1
FSHD2
Fascioscapulohumeral Muscular Dystrophy
Fascioscapulohumeral Muscular Dystrophy Type 1
Fascioscapulohumeral Muscular Dystrophy Type 2
Facioscapulohumeral Muscular Dyst...